{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:20:21Z","timestamp":1789132821623,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL116275"],"award-info":[{"award-number":["T32-HL116275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NCT03733067"],"award-info":[{"award-number":["NCT03733067"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaip.2020.12.024","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T01:49:58Z","timestamp":1609379398000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mapping Out Autoimmunity Control in Primary Immune Regulatory Disorders"],"prefix":"10.1016","volume":"9","author":[{"given":"Jocelyn R.","family":"Farmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.12.024_bib1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.12.024_bib5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaip.2018.11.026","article-title":"The skin as a window into primary immune deficiency diseases: atopic dermatitis and chronic mucocutaneous candidiasis","volume":"7","author":"Lehman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.12.024_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/asheducation.V2012.1.301.3798316","article-title":"The many faces of common variable immunodeficiency","volume":"2012","author":"Cunningham-Rundles","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaip.2020.12.024_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/j.gastro.2015.07.006","article-title":"Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease","volume":"149","author":"Kelsen","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2020.12.024_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10875-016-0339-5","article-title":"Targeted sequencing and immunological analysis reveal the involvement of primary immunodeficiency genes in pediatric IBD: a Japanese multicenter study","volume":"37","author":"Suzuki","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/rheumatology\/kew227","article-title":"High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients","volume":"55","author":"Perazzio","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2020.12.024_bib16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/0961203311411598","article-title":"Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients","volume":"20","author":"Jesus","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaip.2020.12.024_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2020.12.024_bib19","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects","volume":"23","author":"Piqueras","year":"2003","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib22","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2020.12.024_bib23","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3389\/fimmu.2019.02881","article-title":"Failure of B cell tolerance in CVID","volume":"10","author":"Richardson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de Valles-Ibanez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib26","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","article-title":"Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy","volume":"10","author":"Christiansen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.12.024_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2020.12.024_bib29","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.1401876","article-title":"A\u00a0transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells","volume":"194","author":"Hou","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib30","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2020.12.024_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2020.12.024_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.12.024_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2020.12.024_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.12.024_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.12.024_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-015-0455-8","article-title":"Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis","volume":"13","author":"Bertrand","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jaip.2020.12.024_bib37","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.12.024_bib38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2016-10-745174","article-title":"Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations","volume":"129","author":"Hou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib39","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","article-title":"Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells","volume":"121","author":"Kinnunen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.12.024_bib40","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib41","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3389\/fimmu.2018.02012","article-title":"Increased risk for malignancies in 131 affected CTLA4 mutation carriers","volume":"9","author":"Egg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib42","doi-asserted-by":"crossref","first-page":"E4223","DOI":"10.1073\/pnas.1617941114","article-title":"Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab","volume":"114","author":"Ramagopal","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2020.12.024_bib43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2020.12.024_bib44","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fimmu.2019.01544","article-title":"Preponderance of CTLA4 variation associated with autosomal dominant immune dysregulation in the MYPPPY motif","volume":"10","author":"Siggs","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10875-018-0511-1","article-title":"Treatment of intracerebral lesions with abatacept in a CTLA4-haploinsufficient patient","volume":"38","author":"van Leeuwen","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib46","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jamaophthalmol.2016.1013","article-title":"Assessment of CTLA-4 deficiency-related autoimmune choroidopathy response to abatacept","volume":"134","author":"Shields","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaip.2020.12.024_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","article-title":"Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4","volume":"137","author":"Lee","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.12.024_bib48","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a long-term targeted therapy for LRBA deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820313568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820313568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:28:00Z","timestamp":1761974880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820313568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213219820313568"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.12.024","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping Out Autoimmunity Control in Primary Immune Regulatory Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}